Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - OPERATING EXPENSES
Operating Expenses IBRX - ImmunityBio, Inc.
363 M
LAST VALUE
4.67%
2 YEAR CAGR
32.49%
5 YEAR CAGR
62.28%
10 YEAR CAGR